1'758 companies found
Takeda Pharmaceuticals International AG
Glattpark (Opfikon) · Since 2007
Takeda Pharmaceuticals International AG is the regional corporate office of Takeda and serves as the group's regional headquarters. It supports and represents the company’s pharmaceutical activities, including research and development, manufacturing and product distribution.
Tamarind GmbH
Wettingen · Since 2001
The core activity of Tamarind GmbH is the manufacture and distribution of plant-based recipes, in particular products under the protected brands KNOWMORE and YUNNAN BAIYAO.
Tanimswiss Pharma GmbH
Basel · Since 2020
The core activity of Tanimswiss Pharma GmbH is the development, manufacture and distribution of pharmaceutical generics, ayurvedic/herbal medicines, dietary supplements/nutraceuticals and medical devices. The company offers a wide range of products and focuses on improving patient health by providing access to affordable, high-quality medicines and medical devices.
TAP Pharmaceuticals AG
Baar · Since 2017
The core activity of Axarlabs/TaP Pharmaceuticals AG is the end-to-end development of pharmaceutical products, from formulation and process development to marketing. This also includes services such as clinical trials, regulatory strategies, analytics, intellectual property rights and quality management. The company also offers customized project management support and portfolio selection as well as commercial evaluation.
Target BioScience AG
Rüschlikon · Since 2000
The core activity of Target BioScience AG is to provide services in the field of regulatory affairs for the pharmaceutical and biotechnology industry in Switzerland. This includes in particular: Regulatory Affairs: Submission and maintenance of marketing authorization for medicinal products with Swissmedic; Marketing Authorization Holding: Services as holder of the marketing authorization; Quality Management: Consulting and services in the field of quality management; RP Provision: Services as responsible person (Responsible Person); Market Access: Services in the field of market access and price setting. The company thus supports pharmaceutical and biotech companies in complying with regulatory requirements in Switzerland and helps them to bring and maintain their products on the market.
TargImmune Therapeutics AG
Basel · Since 2016
The core activity of TargImmune Therapeutics AG is the development and research of oncological compounds and the development of a modular, synthetic, targeted platform technology for nucleic acid therapy. In particular, the company focuses on the development of targeted apoptosis and immunomodulators (TAIMs) that use synthetic nanoparticles to deliver interchangeable nucleic acid therapeutics directly to the target. The goal is to selectively destroy cancer cells by mimicking natural processes.
Taysha Gene Therapies Switzerland GmbH
Basel · Since 2021
Taysha Gene Therapies Switzerland GmbH is a biopharmaceutical company focused on discovering, developing and commercializing gene therapies for monogenic diseases of the central nervous system (CNS). Its lead clinical program targets Rett syndrome (TSHA-102), an intrathecally delivered AAV9 gene replacement therapy that incorporates a miRNA‑responsive auto‑regulatory element (miRARE) to regulate MECP2 expression.
TECregen AG
Basel · Since 2023
TECregen AG develops, manufactures and distributes pharmaceutical and other healthcare products, and develops, holds and exploits related intellectual property rights.
Telix Pharmaceuticals (Switzerland) Sàrl
Petit-Lancy · Since 1999
The core activity of Telix Pharmaceuticals is the development and manufacture of biopharmaceutical products, in particular targeted radiation products for the diagnosis and treatment of cancer and rare diseases.
Teva Capital Services Switzerland, Zweigniederlassung der Teva Pharmaceuticals International GmbH
Jona · Since 2021
Teva Pharmaceuticals International GmbH
Jona · Since 2000
Teva Pharmaceuticals International GmbH is a pharmaceutical company that develops, manufactures and markets generic and biopharmaceutical medicines. Its operations include research and development across multiple therapeutic areas and global supply‑chain and production activities.
Therakles Pharmaceuticals AG
Baar · Since 2024
therainnova AG
Forch · Since 2021
The core activity of therainnova AG is the provision of strategic and operational consulting services in the field of regulatory affairs for companies in the biopharmaceutical industry in the EU and Switzerland. This includes, among other things: Consulting and support for regulatory procedures and applications, interactions with health authorities, management of submissions and approval applications, creation of orphan designations and pediatric plans, support for due diligence processes and M&A transactions, and interim management of regulatory affairs. The company thus offers a comprehensive range of services to support companies in the biopharmaceutical industry in navigating complex regulatory landscapes and bringing their products to market efficiently.
Theramex Switzerland GmbH
Zurich · Since 2017
Theramex Switzerland GmbH is a pharmaceutical company focused on women’s health, providing treatments and educational resources in areas such as contraception, menopause, osteoporosis and fertility.
Thermo Fisher Diagnostics AG
Reinach Bl · Since 2006
Thermo Fisher Diagnostics AG supplies diagnostic instruments, reagents, consumables, software and related services for clinical laboratories and life‑science research. Its portfolio includes laboratory equipment and analytical systems for sample and material characterization, chemical analysis and clinical diagnostics.
Thermo Fisher Scientific (Schweiz) AG
Reinach Bl · Since 2008
Thermo Fisher Scientific (Schweiz) AG supplies scientific instruments, reagents, consumables, software and services for research, diagnostics, biopharma and industrial laboratories. Its portfolio includes laboratory equipment, antibodies and assays, contract development and manufacturing (CDMO/CRO) services, instrument support and lab informatics solutions.
Tigen Pharma SA
Lausanne · Since 2017
The core activity of Tigen Pharma is the development and acceleration of access to new therapies in the field of cell and gene therapy, particularly for the treatment of cancer. The company combines scientific expertise, technological capabilities and a long-term perspective to develop innovative solutions for patients and society.
TILAB SWISS Sagl
Lugano · Since 2020
The company is primarily active in the manufacture of pharmaceutical products, dietary supplements and cosmetics. It offers a wide range of products, including magistral and official galenic preparations, capsules, ointments, emulsions, liquids, gels and other pharmaceutical forms. The company has a laboratory certified to ISO:9001 and equipped with state-of-the-art technologies and analytical instruments to perform qualitative and quantitative analyses. The company's core activity includes the development, manufacture and marketing of products for health, skin and personal care.
Torpedo Pharmaceuticals AG
Basel · Since 2021
The core activity of Torpedo Pharmaceuticals AG is the development of next-generation radiopharmaceuticals for the treatment of cancer.
Torqur AG
Basel · Since 2021
Torqur AG is a clinical-stage biotechnology company focused on the discovery and development of PI3K/mTOR inhibitors for cancer therapy. The company is developing a portfolio of dual PI3K/mTOR compounds, including the candidate bimiralisib (PQR309) formulated for oral and topical use, and is conducting clinical trials in oncology and dermatology indications.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register